berberine has been researched along with sphingosine kinase in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, H; Jiang, Q; Lan, T; Li, W; Liu, P; Liu, W; Shen, X; Xie, X; Xu, S | 1 |
| Huang, H; Huang, J; Huang, K; Lan, T; Liu, P; Liu, W; Peng, J; Shen, X; Xie, X; Yang, H | 1 |
| Bian, H; Guo, L; Zhang, Q; Zhu, H | 1 |
| Chen, R; Jiang, G; Luo, J; Qin, X; Wang, L; Yu, J; Zeng, S | 1 |
| Chen, J; Han, H; Liu, W; Lu, J; Pan, R; Yi, Y; Zhang, C | 1 |
| Chen, Y; Cui, K; Lan, R; Li, R; Ling, L; Liu, J; Liu, K; Luan, Y; Rao, K; Ruan, Y; Song, J; Sun, T; Wang, S; Wang, T; Yuan, P | 1 |
6 other study(ies) available for berberine and sphingosine kinase
| Article | Year |
|---|---|
Berberine ameliorates renal injury in diabetic C57BL/6 mice: Involvement of suppression of SphK-S1P signaling pathway.
Topics: Albuminuria; Animals; Berberine; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glucose; Kidney; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; Phosphotransferases (Alcohol Group Acceptor); Random Allocation; Signal Transduction; Sphingosine; Transforming Growth Factor beta1 | 2010 |
Berberine suppresses high glucose-induced TGF-β1 and fibronectin synthesis in mesangial cells through inhibition of sphingosine kinase 1/AP-1 pathway.
Topics: Actins; Animals; Berberine; Cells, Cultured; Diabetic Nephropathies; Dose-Response Relationship, Drug; Down-Regulation; Fibronectins; Glucose; Humans; Hypertrophy; Mesangial Cells; Phosphotransferases (Alcohol Group Acceptor); Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Signal Transduction; Transcription Factor AP-1; Transfection; Transforming Growth Factor beta1 | 2012 |
Berberine Preconditioning Protects Neurons Against Ischemia via Sphingosine-1-Phosphate and Hypoxia-Inducible Factor-1[Formula: see text].
Topics: Animals; Berberine; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Ischemia; Lysophospholipids; Male; Neurons; Neuroprotective Agents; Phosphotransferases (Alcohol Group Acceptor); Rats; Rats, Sprague-Dawley; Sphingosine | 2016 |
The effects of berberine on a murine model of multiple sclerosis and the SPHK1/S1P signaling pathway.
Topics: Animals; Berberine; Encephalomyelitis, Autoimmune, Experimental; Female; Lysophospholipids; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Neuroprotective Agents; Phosphotransferases (Alcohol Group Acceptor); Signal Transduction; Sphingosine; Spinal Cord | 2017 |
Berberine protects HK-2 cells from hypoxia/reoxygenation induced apoptosis via inhibiting SPHK1 expression.
Topics: Animals; Apoptosis; Berberine; Caspase 3; Caspase 9; Cell Hypoxia; Cell Proliferation; Humans; Phosphotransferases (Alcohol Group Acceptor) | 2018 |
Berberine ameliorates erectile dysfunction in rats with streptozotocin-induced diabetes mellitus through the attenuation of apoptosis by inhibiting the SPHK1/S1P/S1PR2 and MAPK pathways.
Topics: Animals; Apoptosis; Berberine; Diabetes Mellitus, Experimental; Erectile Dysfunction; Lysophospholipids; Male; MAP Kinase Signaling System; Phosphotransferases (Alcohol Group Acceptor); Rats; Signal Transduction; Sphingosine; Sphingosine-1-Phosphate Receptors; Streptozocin | 2022 |